Report Highlights
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Report Includes
- 27 tables
- An overview of the global market and technologies for microbial products with special focus on their applications
- Estimation of the market size and analyses of global market trends, with data from 2019-2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential and quantification of microbial products market based on type, application, and region
- Detailed descriptions of probiotics, their types, and recent developments and information on microbial pesticides and biofertilizers and their potential uses
- Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry, including Seres Therapeutics, Enterome Biosciences, Ferring Pharmaceutics, Evelo Biosciences, Finch Therapeutics, Microbiome Therapeutics, and Pylum Biosciences
Report Scope
This report addresses the global market for microbes and microbial products used in commercial applications from 2021 through 2027. This includes agricultural, healthcare, manufacturing, energy, and environmental applications.
Viruses are sometimes classified as microbes, but they are nonliving, and thus they are excluded from this report.
Major elements cited in this study include:
- Summary.
- Definitions.
- Description of microbes.
- Microbe end-uses and applications.
- Regulation.
- Recent technological developments.
- Market size and segmentation from 2021 to 2027.
- Company profiles.
- Key patents.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $229.9 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $346.3 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 7.4% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | Segment, product type, end-use, region | ||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Canada, Germany, France, U.K., Spain, Italy, Russia, China, India, Japan, South Korea, Australia, and Singapore | ||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Novozymes
- Lam International
- Amgen
- Novo Nordisk
- Evolva
- Amyris
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.
Report Includes
- 29 data tables and 21 additional tables
- An overview of the global market for microbial products, technologies, and applications
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Identifications of microbial applications in a wide range of fields, i.e., agriculture, healthcare, manufacturing, energy, and environment
- Information about microbial pesticides and biofertilizers and their potential uses
- Detailed descriptions of probiotics, their types, and recent developments
- Coverage of microbial fuel cell technologies and their types, i.e., mediator microbial fuel cells, microbial electrolysis cells, soil-based microbial fuel cells, phototropic biofilm microbial fuel cells, and nanoporous membrane microbial fuel cells
- Comprehensive company profiles of major players in the market, including Certis USA LLC, Taiwan Chlorella Manufacturing Co., Amgen Inc., Leadiant, AB Mauri, Genencor, and Amyris Inc.
Report Highlights
The global market for microbes and microbial products was valued at $143.5 billion in 2014. The 2015 market is projected to approach $154.7 billion, and the 2020 market, nearly $306 billion, with a compound annual growth rate (CAGR) of 14.6% from 2015 to 2020.
Report Includes
- An overview of the global market for microbial products, technologies and their applications.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Information gathered from developers, vendors, and users of microbial products for commercial applications.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $117 billion in 2012. The 2013 market is projected to approach $134 billion, and, by 2018, $179 billion, with a projected five year compound annual growth rate (CAGR) of 6%.
Report Includes
- An overview of the global market for microbes and microbial products.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $144 billion in 2010. The 2011 market is projected to exceed $156 billion, and, by 2016, $259 billion, reflecting a 10.7% projected compound annual growth rate (CAGR) between 2011 and 2016.
Related Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.
Global Algae and Seaweed Protein Market
The global market for algae and seaweed protein reached $904.7 million in 2022. The market is estimated to grow from $962.8 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 6.8% from 2023 through 2028.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More